Search
Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.
News
06 May 2024
On April 30, 2024, the Federal Trade Commission (FTC) announced that it sent a new set of warning letters to ten pharmaceutical companies. The letters inform the companies that the...
Insights and Analysis
01 May 2024
Our 10th annual M&A Year in Review features a 2024 M&A Outlook, which provides insights across the key topics that we expect will influence dealmaking in the months to come:...
News
25 April 2024
The UK High Court has ruled against the Competition Appeal Tribunal (“CAT”) in a case about the power of the Competition and Markets Authority (“CMA”) to search...
News
25 April 2024
On April 23, 2024, the Federal Trade Commission (FTC) voted to publish a final rule that, effective 120 days after publication, will ban the use of non-compete clauses nationwide,...
Insights and Analysis
23 April 2024
On April 17, 2024, the General Law of Adequate and Sustainable Food (the “Law”) was published on the Federal Official Gazette, whose principles and bases are aimed at protecting ...
Insights and Analysis
22 April 2024
On April 17, 2024, the General Law of Adequate and Sustainable Food (the “Law”) was published on the Federal Official Gazette, whose principles and bases are aimed at protecting ...
News
22 April 2024
The UK Competition and Markets Authority (“CMA”) has published an “Update Paper” outlining its evolving views on AI foundation models as well as its approach to...
News
05 April 2024
With the recent filing of an amicus brief in a private pharmaceutical patent infringement case, the Federal Trade Commission (FTC) has continued its focus on allegedly “improperly...
Insights and Analysis
05 April 2024
Offering an alternative between payment and advertising is not per se contrary to the freedom of consent under the GDPR.
